E2/ERβ Inhibits PPARα to Regulate Cell-Proliferation and Enhance Apoptosis in Hep3B-Hepatocellular Carcinoma

[1]  D. Cho,et al.  An acute bleeding metastatic spinal tumor from HCC causes an acute onset of cauda equina syndrome , 2015, BioMedicine.

[2]  P. Misra,et al.  Peroxisome proliferator-activated receptor-α activation and excess energy burning in hepatocarcinogenesis. , 2014, Biochimie.

[3]  P. Kaldis,et al.  The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations , 2014, Cancers.

[4]  Y. Gong,et al.  Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E. , 2012, Gastroenterology.

[5]  M. Badr,et al.  Peroxisome proliferator‐activated receptors and cancer: challenges and opportunities , 2011, British journal of pharmacology.

[6]  C. Oostenbrink,et al.  Molecular mechanism of allosteric communication in the human PPARα‐RXRα heterodimer , 2010, Proteins.

[7]  M. Fidaleo.  Human health risk assessment for peroxisome proliferators: more than 30 years of research. , 2009, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[8]  K. Mitsumori,et al.  Role of Nrf2 and oxidative stress on fenofibrate-induced hepatocarcinogenesis in rats. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[9]  G. Carruba.  Estrogen and prostate cancer: An eclipsed truth in an androgen‐dominated scenario , 2007, Journal of cellular biochemistry.

[10]  P. Burfeind,et al.  The relevance of estrogen receptor-β expression to the antiproliferative effects observed with histone deacetylase inhibitors and phytoestrogens in prostate cancer treatment , 2007, Molecular Cancer Therapeutics.

[11]  I. Fichtner,et al.  Loss of tumourigenicity of stably ERβ-transfected MCF-7 breast cancer cells , 2007, Molecular and Cellular Endocrinology.

[12]  Sunhyo Jeong,et al.  Inhibition of the Actions of Peroxisome Proliferator‐activated Receptor α on Obesity by Estrogen , 2007 .

[13]  K. Mitsumori,et al.  Effect of fenofibrate on oxidative DNA damage and on gene expression related to cell proliferation and apoptosis in rats. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  K. Morimura,et al.  Peroxisome Proliferator-Activated Receptor α Regulates a MicroRNA-Mediated Signaling Cascade Responsible for Hepatocellular Proliferation , 2007, Molecular and Cellular Biology.

[15]  J. Bergh,et al.  Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer , 2007, Breast Cancer Research.

[16]  R. Ringseis,et al.  Feeding oxidized fat during pregnancy up-regulates expression of PPARα-responsive genes in the liver of rat fetuses , 2007, Lipids in Health and Disease.

[17]  O. Ortmann,et al.  Novel estrogen receptor beta transcript variants identified in human breast cancer cells affect cell growth and apoptosis of COS-1 cells , 2007, Molecular and Cellular Endocrinology.

[18]  Shin-Da Lee,et al.  Apoptotic and anti-proliferative effects of 17β-estradiol and 17β-estradiol-like compounds in the Hep3B cell line , 2006, Molecular and Cellular Biochemistry.

[19]  Philippe Lefebvre,et al.  Sorting out the roles of PPARα in energy metabolism and vascular homeostasis , 2006 .

[20]  G. Lazennec.  Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. , 2006, Cancer letters.

[21]  Frank J. Gonzalez,et al.  Peroxisome proliferator-activated receptor-α and liver cancer: where do we stand? , 2005, Journal of Molecular Medicine.

[22]  E. J. Lee,et al.  Expression of estrogen receptor β in prostate carcinoma cells inhibits invasion and proliferation and triggers apoptosis , 2004, FEBS letters.

[23]  N. Marx,et al.  Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. , 2004, Circulation research.

[24]  J. Bruix,et al.  Focus on hepatocellular carcinoma. , 2004, Cancer cell.

[25]  J. Hartman,et al.  Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D , 2004 .

[26]  G. Firestone,et al.  Estrogen Receptor β Inhibits Human Breast Cancer Cell Proliferation and Tumor Formation by Causing a G2 Cell Cycle Arrest , 2004, Cancer Research.

[27]  Peter Olson,et al.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0288 Minireview: Lipid Metabolism, Metabolic Diseases, and , 2022 .

[28]  M. Pagano,et al.  Regulation of the Cdk inhibitor p27 and its deregulation in cancer , 2000, Journal of cellular physiology.

[29]  J. Reddy,et al.  Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. , 2000, Mutation research.

[30]  J. Peters,et al.  Suppression of mouse hepatocyte apoptosis by peroxisome proliferators : role of PPARα and TNFα , 2000 .

[31]  J. Peters,et al.  Mechanism of Action of the Nongenotoxic Peroxisome Proliferators: Role of the Peroxisome Proliferator-Activated Receptor α , 1998 .

[32]  J. Reddy,et al.  Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens , 1980, Nature.

[33]  T. P. Krishnakantha,et al.  Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate , 1975, Science.

[34]  Sunhyo Jeong,et al.  Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen. , 2007, Obesity.

[35]  B. Staels,et al.  Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. , 2006, The Journal of clinical investigation.

[36]  Shin-Da Lee,et al.  Apoptotic and anti-proliferative effects of 17beta-estradiol and 17beta-estradiol-like compounds in the Hep3B cell line. , 2006, Molecular and Cellular Biochemistry.

[37]  J. Peters,et al.  Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand? , 2005, Journal of molecular medicine.

[38]  J. Hartman,et al.  Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Firestone,et al.  Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. , 2004, Cancer research.

[40]  J. Peters,et al.  Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARalpha and TNFalpha. , 2000, Mutation research.

[41]  W. Meyers,et al.  Hepatocellular carcinoma. , 1998, The British journal of surgery.

[42]  J. Peters,et al.  Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. , 1998, Journal of the National Cancer Institute.